Patents by Inventor Hubert Vidal

Hubert Vidal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240335497
    Abstract: A pulse protein composition, preferably of pea or faba bean, the degree of hydrolysis of which is less than 10%, in particular for therapeutic use, preferably in the prevention and/or treatment of a disease susceptible to treatment by activation of the synthesis of FGF19.
    Type: Application
    Filed: July 26, 2022
    Publication date: October 10, 2024
    Inventors: Catherine LEFRANC-MILLOT, Hubert VIDAL, Clémence DEFOIS
  • Patent number: 10695403
    Abstract: The present invention relates to an FGF19 polypeptide for use in increasing muscle fiber size in the treatment of muscle atrophy in a mammal.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: June 30, 2020
    Assignees: Universite Claude Bernard Lyon, Institut National de la Recherche Agronomique (INRA), Institut National de la Santè et de la Recherche Médicale (INSERM), Bergen Teknologioverforing AS
    Inventors: Emmanuelle Fouilloux-Meugnier, Hubert Vidal, Jérome Ruzzin
  • Publication number: 20180369331
    Abstract: The present invention relates to a FGF19 polypeptide for its use as an agent increasing muscle fibers size, in the prevention and/or treatment of muscle atrophy in a mammal body.
    Type: Application
    Filed: June 24, 2016
    Publication date: December 27, 2018
    Applicants: Universite Claude Bernard Lyon 1, Institut National De La Recherche Agronomique (INRA), Institut National De La Santé Et De La Recherche Médicale (INSERM), Bergen Teknologioverforing AS
    Inventors: Emmanuelle FOUILLOUS-MEUGNIER, Hubert VIDAL, Jérôme RUZZIN
  • Publication number: 20090220958
    Abstract: The invention relates to a method for diagnosticating hepatic diseases consisting in measuring an apolipoprotein A4 expression in hepatic cells or tissues and in the circulation (blood, plasma, serum. A method for screening molecules for treating said diseases by bringing into contact said compounds with a mammal and for measuring the apolipoprotein A4 expression in said hepatic origin cells or in the circulation of said mammal is also disclosed.
    Type: Application
    Filed: November 10, 2006
    Publication date: September 3, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Pierre Casellas, Hubert Vidal, Isabelle Buisson, Jean Marchand, Dominique Simon, Sylvaine Galiegue